|
Volumn 382, Issue 6588, 1996, Pages 211-212
|
Breaking the curse of the AGEs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGUANIDINE;
GLUCOSE;
GLYCOSYLATED PROTEIN;
INSULIN;
N PHENACYLTHIAZOLIUM BROMIDE;
UNCLASSIFIED DRUG;
ADVANCED GLYCATION END PRODUCT;
CELL SURFACE RECEPTOR;
CROSS LINKING REAGENT;
DROSOPHILA PROTEIN;
FRIZZLED PROTEIN;
FZ2 PROTEIN, DROSOPHILA;
G PROTEIN COUPLED RECEPTOR;
NEUROTRANSMITTER RECEPTOR;
PROTEIN;
ATHEROSCLEROSIS;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
DRUG DESIGN;
DRUG MECHANISM;
GLUCOSE BLOOD LEVEL;
GLYCATION;
HUMAN;
INSULIN RELEASE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN CROSS LINKING;
SHORT SURVEY;
ANIMAL;
BLOOD;
GENETICS;
METABOLISM;
NOTE;
PHYSIOLOGY;
RAT;
ANIMALS;
BLOOD GLUCOSE;
CROSS-LINKING REAGENTS;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
DROSOPHILA PROTEINS;
DRUG DESIGN;
FRIZZLED RECEPTORS;
GLYCOSYLATION END PRODUCTS, ADVANCED;
HUMANS;
PROTEINS;
RATS;
RECEPTORS, CELL SURFACE;
RECEPTORS, G-PROTEIN-COUPLED;
RECEPTORS, NEUROTRANSMITTER;
|
EID: 0029994516
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/382211a0 Document Type: Short Survey |
Times cited : (19)
|
References (9)
|